表紙
市場調査レポート

世界の光学画像市場の見通し:臨床診断・臨床研究・ライフサイエンスにおけるOCT・HIS・NIRS・PATのアプリケーションと技術動向

Optical Imaging Market (2013-2018) - Technology Trends And Applications of OCT, HSI, NIRS and PAT in Clinical Diagnostics, Clinical Research And Life Sciences With Market Landscape Analysis - Estimates Up To 2018

発行 MarketsandMarkets 商品コード 263733
出版日 ページ情報 英文 147 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.75円で換算しております。
Back to Top
世界の光学画像市場の見通し:臨床診断・臨床研究・ライフサイエンスにおけるOCT・HIS・NIRS・PATのアプリケーションと技術動向 Optical Imaging Market (2013-2018) - Technology Trends And Applications of OCT, HSI, NIRS and PAT in Clinical Diagnostics, Clinical Research And Life Sciences With Market Landscape Analysis - Estimates Up To 2018
出版日: 2013年03月04日 ページ情報: 英文 147 Pages
概要

世界の医療分野におけるファイバー光学、オプティクス市場はこの十年間で大きく発展してきております。

当レポートでは、世界の光学画像市場について調査分析を行い、光コヒーレンストモグラフィ(Oct)、ハイパースペクトラルイメージング(Hsi)、近赤外分光法(Nirs)、光音響トモグラフィー(Pat)などの技術の臨床診断、臨床研究、生命科学分野での動向や応用、バリューチェーン分析、市場分析、規制分析、技術開発、投資機会、競合状況、主要企業のプロファイルなどについてまとめ、概略下記の構成で取り上げております。

第1章 イントロダクション

  • 主な調査結果
  • レポートの範囲
  • レポートのセグメンテーション
  • 調査方法
  • 仮定

第2章 エグゼクティブサマリー

第3章 技術概要

  • 技術の概要
  • 米国、欧州の臨床医学における光学画像
  • 技術動向
  • 技術のセグメンテーション
  • 商用のモダリティ
  • 光学画像モダリティVS従来のモダリティ
  • 光コヒーレンストモグラフィ(Oct)
  • ハイパースペクトラルイメージング(Hsi)
  • 近赤外分光法(Nirs)
  • 光音響トモグラフィー(Pat)
  • 技術ロードマップ
  • 技術の範囲:Oct
  • 技術の範囲:ハイパースペクトラルイメージングと近赤外分光法

第4章 バリューチェーン分析

第5章 市場の状況分析

  • 市場の状況分析の概要
  • 米国のOct市場の状況分析
  • EUのOct市場の状況分析
  • 市場のダイナミクス

第6章 規制状況分析

  • 規制状況分析

第7章 技術導入/開発の潜在性:地域別

  • 地域別導入/開発の潜在性

第8章 投資家分析/投資機会

  • 投資家ネットワーク
  • Octへの資金
  • Oct:アメリカ国立衛生研究所/アメリカ国立科学財団/欧州委員会、大学別
  • ハイパースペクトラルイメージング、近赤外分光法、光音響トモグラフィー
  • 潜在的投資機会

第9章 競合状況分析

  • 主要企業の市場シェア
  • 主なM&A
  • 主な提携/契約/協力
  • 主な製品の発売
  • Oct競合状況

第10章 アナリストによる考察/提案

  • アナリストの考察

第11章 企業プロファイル

  • Michelson Diagnostics Ltd (Vivosight)
  • Carl Zeiss Meditec
  • Heidelberg Engineering
  • St. Jude Medical
  • Volcano Corporation
  • Headwall Photonics, Inc.
  • Raytheon Elcan Optical Technologies
  • Chemimage Corporation
  • Cytoviva, Inc.
  • Somanetics Corporation
  • Topcon Medical Systems, Inc.
  • Ase Optics
  • Bioptigen, Inc

第12章 付録

図表

目次
Product Code: MD 1354

Title: Optical Imaging Market (2013-2018) - Technology Trends and Applications of Optical Coherence Tomography (OCT), Hyper Spectral Imaging (HSI), Near Infrared Spectroscopy (NIRS) and Photo- Acoustic Tomography (PAT) in Clinical Diagnostics, Clinical Research and Life Sciences with Market Landscape Analysis - Estimates Up to 2018.

Optical Imaging is an emerging medical technology that uses light to assess optical properties of tissues, and has a great potential for improving disease prevention, clinical research, medical diagnosis and treatment. The basic principle involves - the detection of emitted photons at pre-defined wavelength ranges when the fluorescent probes in the optical imaging system can be excited by NIR light. Further advancements and breakthroughs in the field of fiber optics and photonics resulted in the emergence of innovative technologies such as Optical Coherence Tomography (OCT), Photo-Acoustic Tomography (PAT), Hyper-Spectral Imaging (HSI) and Near-Infrared Spectroscopy (NIRS) that have a potential to redefine the fields of clinical diagnostics and research. These technologies have an ability distinguish the diverse soft tissues based on photon absorption and scattering differences among the soft tissues enhancing the accuracy of clinical research and pathological diagnosis. Though these technologies are still in the early phase of development, they offer a number of advantages (such as non-invasiveness and use of no ionizing radiation) over existing radiological screening techniques.

This research report is categorized into OCT, PAT, HSI and NIRS and is further classified as follows:

Source: MarketsandMarkets Analysis

Global optical imaging market is anticipated to be approximately around $1.9 billion by end of 2018, growing at a CAGR of 11.37%. Among the modalities, OCT occupies a major share contributing over 70% of the total optical imaging market. America is the major markets followed by Europe, and have been driving the market significantly owing to the increase in aging population across the developed economies. Emerging economies such as Asia-pacific and Middle-East are the future drivers of this market.

Source: MarketsandMarkets Analysis

This report is further divided into segments and sub-segments providing exhaustive market analysis with respect to each technology from the years 2010 and 2011, as well as forecast up to 2018. Each technology is comprehensively analyzed at a granular level by geography (North America, EU, Asia and rest of the world) to provide in-depth information on the global scenario. Investment opportunity evaluation and emerging initial public offerings (IPOs) can be assessed within the optical imaging sector. Strategic recommendations for technology developers are elaborately discussed in this research service.

Multi-modality imaging using fibre-optics principles boosts the development of novel therapeutics and early detection of chronic diseases. Advancements in these modalities enable clinicians to visualize better views of anatomical structure and function, both at the molecular and cellular levels.

Drivers:

A key driving force is the technology's immense application scope for easy access to visualize and image in-depth structures of eye, surface tissues, mucosal membranes, the gastrointestinal tract, and vascular systems. They also enhance the drug discovery process by enabling better imaging of tissues and other biological entities at the molecular level. A major advantage of using optical imaging includes operator safety, patient comfort and patient safety. In the future, most of these technologies will gain widespread clinical acceptance and find specific roles in the clinical medicine.

Challenges:

  • Inadequate clinical data validation for optical methods restricts adoption.
  • Lack of reimbursement facilities.

The key players profiled in the report are Michelson Diagnostics, Heidelberg Engineering GmBH, Carl Zeiss Meditec, Volcano Corporation, Topcon Medical Systems Inc., St. Jude Medical Inc., Headwall Photonics, Cytoviva Inc., ChemImage Corporation, Bioptigen Inc., Raytheon ELCAN Optical Technologies, Somanetics Corporation and ASE Optics Inc.

Scope of the Report:

The research service on “Advances in Optical Imaging in Clinical Diagnostics & Clinical Research - Technology Trends and Market Landscape Analysis” is an attempt to showcase the technology and market impact of existing and emerging fibre-optics based technologies having an immense growth potential in clinical medicine for the next five years. This technology based research report categorizes optical imaging market based on technology, applications and based on geography.

Based on Technology:

The report covers the technical aspects of OCT, PAT, NIRS and HSI along with investment potentials. Quantitative data analysis and growth rates of OCT are provided for the North America and European regions and potential addressable market for other technology segments are mentioned in the report.

Based on Geography:

The technologies in this report were thoroughly based on geographies -North America, Europe, Asia, and Rest of the World (ROW) providing in-depth information on market size, share and segmentation. The report also provides information on adoption and development potential of OCT, HSI, NIRS and PAT technologies in these regions.

Reasons to buy the Report

This report service on optical imaging in clinical medicine comprehends 75% of its focus on technological understanding and 25% of market engineering standards. There is only one recent available report on Optical Imaging Devices and it does not include market numbers. So this report would be the first holistic report which analyses in depth about technology as well as market landscape of optical imaging market.

Table of Contents

1. Introduction

  • 1.1. Key Take- Aways
  • 1.2. Report Scope
  • 1.3. Report Segmentation
  • 1.4. Research Methodology
  • 1.5. Assumptions

2. Executive Summary

3. Technology Snapshot

  • 3.1. Technology Overview
  • 3.2. Optical Imaging In Clinical Medicine For The U.S. And Eu Regions
  • 3.3. Technology Trends
  • 3.4. Technology Segmentation
  • 3.5. Commercially Available Modalities
  • 3.6. Optical Imaging Modalities Vs Conventional Modalities
  • 3.7. Optical Coherence Tomography (Oct)
  • 3.8. Hyper Spectral Imaging (Hsi)
  • 3.9. Near Infrared Spectroscopy (Nirs)
  • 3.10. Photo- Acoustic Tomography (Pat)
  • 3.11. Technology Roadmap
  • 3.12. Technology Scope-Oct
  • 3.13. Technology Scope - Hyper Spectral Imaging & Near Infrared Spectroscopy

4. Value Chain Analysis

5. Market Landscape Analysis

  • 5.1. Market Landscape Analysis-Overview
    • 5.1.1. Market Evaluation & Assessment, By Technology
    • 5.1.2. Market Evaluation & Assessment, By Geography
    • 5.1.3. Market Evaluation & Assessment, By Applications
  • 5.2. U.S. Oct Market Landscape Analysis
    • 5.2.1. U.S. Oct For Clinical Diagnostics -Ophthalmology, Dentistry, Cardiology, Dermatology, Oncology & Others
    • 5.2.2. U.S. Oct For Clinical Research & Life Sciences For Biomedical Research, Drug Discovery & Pre-Clinical Imaging
  • 5.3. European Union Oct Market Landscape Analysis
    • 5.3.1. European Union Oct For Clinical Diagnostics -Ophthalmology, Dentistry, Cardiology, Dermatology, Oncology & Others
    • 5.3.2. European Union Oct For Clinical Research & Life Sciences For Biomedical Research, Drug Discovery & Pre-Clinical Imaging
  • 5.4. Market Dynamics
    • 5.4.1. Drivers
    • 5.4.2. Restraints

6. Regulatory Landscape Analysis

  • 6.1. Regulatory Landscape Analysis - Overview
    • 6.1.1. Regulatory Analysis - Region Wise
    • 6.1.2. Regulatory Landscape Analysis - Country Wise

7. Technology Adoption & Development Potential - By Geography

  • 7.1. Geographic Adoption & Development Potential
    • 7.1.1. Americas
    • 7.1.2. Europe
    • 7.1.3. Row

8. Investor Analysis & Investment Opportunities

  • 8.1. Investor Network - Federal Funding Agencies, Regional Government Funding, Corporate Investors, Venture Capitalists & Private Equity Firms
  • 8.2. Oct Funding
  • 8.3. Oct National Institute Of Health/National Science Foundation/European Commission Funding, By University
  • 8.4. Hyper Spectral Imaging, Near Infrared Spectroscopy & Photo- Acoustic Tomography Funding
  • 8.5. Potential Investment Opportunities

9. Competitive Landscape Analysis

  • 9.1. Key Company Market Share
  • 9.2. Key Mergers & Acquisitions (2009-2012)
  • 9.3. Key Partnerships/Agreements/Collaborations (2009-2012)
  • 9.4. Key Product Launches (2009-2012)
  • 9.5. Oct Competitive Analysis

10. Analyst Insights & Recommendations

  • 10.1. Analyst Insights
    • 10.1.1. Analyst Insights - By Technology
    • 10.1.2. Business Strategies Based Analyst Insights
    • 10.1.3. Analyst Recommendations

11. Company Profiles

  • 11.1 Michelson Diagnostics Ltd ( Vivosight)
  • 11.2 Carl Zeiss Meditec
  • 11.3 Heidelberg Engineering
  • 11.4 St. Jude Medical
  • 11.5 Volcano Corporation
  • 11.6 Headwall Photonics, Inc.
  • 11.7 Raytheon Elcan Optical Technologies
  • 11.8 Chemimage Corporation
  • 11.9 Cytoviva, Inc.
  • 11.10 Somanetics Corporation
  • 11.11 Topcon Medical Systems, Inc.
  • 11.12 Ase Optics
  • 11.13 Bioptigen, Inc.

12. Appendix

List Of Tables

  • 1. Global Optical Imaging Market (2011-2018)- By Technology, By Revenue ($Million)
  • 2. Global Oct Market (2011-2018)- By Geography, By Revenue ($Million)
  • 3. Optical Imaging Market (2011-2018)- By Geography, By Revenue ($Million)
  • 4. Optical Imaging Market (2011-2018)- By Applications, By Revenue ($Million)
  • 5. U.S. Optical Coherence Tomography Market (2011-2018)- By Applications, By Revenue ($Million)
  • 6. U.S. Optical Coherence Tomography For Clinical Diagnostics (2011-2018)- By Applications, By Revenue ($Million)
  • 7. U.S. Optical Coherence Tomography For Clinical Research (2011-2018)- By Applications, By Revenue ($Million)
  • 8. Eu Optical Coherence Tomography Market (2011-2018)- By Applications, By Revenue ($Million)
  • 9. Eu Optical Coherence Tomography For Clinical Diagnostics (2011-2018)- By Applications, By Revenue ($Million)
  • 10. European Union Optical Coherence Tomography For Clinical Research (2011-2018)- By Applications ,By Revenue ($Million)

List Of Figures

  • 1. Global Optical Imaging Market, By Technology, By Revenues, 2011-2018 ($Million)
  • 2. Optical Imaging Market Share, 2012, By Technology
  • 3. Global Optical Imaging Market, By Geography, By Revenues (2012-2018)
  • 4. Optical Imaging Market Growth Forecast, By Geography (2012-2018)
  • 5. U.S. Oct- Clinical Diagnostics Market 2012, By Applications
  • 6. European Union Oct For Clinical Diagnostics (2011-2018) By Applications, By Revenues ($Million)
  • 7. Global Optical Imaging Market (2011-2018), By Market Revenues ($Million)
  • 8. Global Optical Imaging Market Forecast(2011-2018), By Technology, By Revenues ($Million)
  • 9. Global Oct Market (2011-2018), By Revenues ($Million)
  • 10. Hyper Spectral Imaging Market (2011-2018), By Revenues ($Million)
  • 11. Near Infrared Spectroscopy & Photo- Acoustic Tomography Market (2011- 2018), By Revenues ($Million)
  • 12. Optical Imaging Market 2012 , By Technology
  • 13. Global Oct Market (2011-2018), By Geography, By Revenues
  • 14. Optical Imaging Market 2012, By Geography
  • 15. Optical Imaging Technologies, By Applications, By Revenues (2012-2018)
  • 16. U.S. Oct Market 2012, By Applications
  • 17. U.S. Oct - Clinical Diagnostics Market 2012, By Applications
  • 18. U.S. Oct For Clinical Diagnostics (2011-2018), By Applications, By Revenues ($Million)
  • 19. U.S. Oct For Clinical Research (2011-2018), By Applications, By Market Share ($Million)
  • 20. U.S. Oct For Lifesciences Research (2011-2018) , By Applications, By Market Share ($Million)
  • 21. European Union Oct Market (2011-2018), By Applications
  • 22. European Union Oct Clinical Diagnostics Market (2011-2018), By Applications, By Revenues ($Million)
  • 23. European Union Oct Clinical Diagnostics Market Share 2012, By Ap Applications
  • 24. European Union Oct For Clinical Research (2011-2018), By Applications, By Revenues ($Million)
  • 25. European Union Oct For Lifesciences Research (2011-2018), By Applications, By Revenues ($Million)
  • 26. Regulatory Landscape
  • 27. Optical Maging Market, By Geography, 2013 - 2018 (Cagr%)
  • 28. Investors Network - Federal Funding Agencies, Regional Government Funding,Corporate Investors, Venture Capitalists & Private Equity Firms
  • 29. Investors Funding 2012
  • 30. Year-Wise National Institute Of Health Funding ($Million)
  • 31. European Commission, National Science Foundation & Canadian Funding ($Million)
  • 32. Potential Investment Opportunities
  • 33. Competitive Landscape
  • 34. Key Company Market Share
  • 35. Oct Competitive Landscape Analysis (2012)
  • 36. No. Of Oct Companies (2008-2013)
Back to Top